Added value of FDG-PET for detection of progressive supranuclear palsy
Authors:
- Ralph BuchertRBRalph Buchert
- Hans-Jürgen HuppertzHHHans-Jürgen Huppertz
- Florian WegnerFWFlorian Wegner
- Georg BerdingGBGeorg Berding
- Ivayla ApostolovaIAIvayla Apostolova
- Carsten BuhmannCBCarsten Buhmann
- Monika Poetter-NergerMPMonika Poetter-Nerger
- Sabrina KatzdoblerSKSabrina Katzdobler
- Martin KlietzMartin Klietz
- Johannes LevinJLJohannes Levin
Open Access
- 6 August 2024
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 96 (3) , 287-295
Abstract
Background: Diagnostic criteria for progressive supranuclear palsy (PSP) include midbrain atrophy in MRI and hypometabolism in [18F]fluorodeoxyglucose (FDG)-positron emission tomography (PET) as supportive features. Due to limited data regarding their relative and sequential value, there is no recommendation for an algorithm to combine both modalities to increase diagnostic accuracy. This study evaluated the added value of sequential imaging using state-of-the-art methods to analyse the images regarding PSP features.Methods: The retrospective study included 41 PSP patients, 21 with Richardson’s syndrome (PSP-RS), 20 with variant PSP phenotypes (vPSP) and 46 sex- and age-matched healthy controls. A pretrained support vector machine (SVM) for the classification of atrophy profiles from automatic MRI volumetry was used to analyse T1w-MRI (output: MRI-SVM-PSP score). Covariance pattern analysis was applied to compute the expression of a predefined PSP-related pattern in FDG-PET (output: PET-PSPRP expression score).Results: The area under the receiver operating characteristic curve for the detection of PSP did not differ between MRI-SVM-PSP and PET-PSPRP expression score (p≥0.63): about 0.90, 0.95 and 0.85 for detection of all PSP, PSP-RS and vPSP. The MRI-SVM-PSP score achieved about 13% higher specificity and about 15% lower sensitivity than the PET-PSPRP expression score. Decision tree models selected the MRI-SVM-PSP score for the first branching and the PET-PSPRP expression score for a second split of the subgroup with normal MRI-SVM-PSP score, both in the whole sample and when restricted to PSP-RS or vPSP.Conclusions: FDG-PET provides added value for PSP-suspected patients with normal/inconclusive T1w-MRI, regardless of PSP phenotype and the methods to analyse the images for PSP-typical features.Keywords
This publication has 40 references indexed in Scilit:
- Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of ParkinsonismsMovement Disorders Clinical Practice, 2021
- Conventional Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Disorders: A Meta‐AnalysisMovement Disorders Clinical Practice, 2020
- Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal SyndromeJAMA Neurology, 2020
- Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classificationMovement Disorders, 2016
- The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite casesMovement Disorders, 2014
- Characterization of disease‐related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scannersHuman Brain Mapping, 2013
- Fluorodeoxyglucose positron emission tomography in Richardson's syndrome and progressive supranuclear palsy‐parkinsonismMovement Disorders, 2011
- Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP‐CIT PET analysesMovement Disorders, 2008
- The Alzheimer's disease neuroimaging initiative (ADNI): MRI methodsJournal of Magnetic Resonance Imaging, 2008
- Abnormal metabolic networks in atypical parkinsonismMovement Disorders, 2008